TNF and in situ carcinoma: The CIS cells begun to express TNF-α/NF-kB, apoptosis, P53, estrogen response, hypoxia, PI3K/AKT/mTOR, and glycolysis-related genes, and which were further aggravated in the malignant cells (Fig. 2c).